Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unit.

Schultz MJ, Baas MC, van der Sluijs HP, Stamkot GA, Smit W.

Curr Med Chem. 2006;13(21):2565-70. Review.

PMID:
17017911
2.

Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.

van den Berk G, Tonino S, de Fijter C, Smit W, Schultz MJ.

Crit Care. 2005 Aug;9(4):361-70. Epub 2005 Jan 7. Review.

3.

[Iodinated contrast agent-induced nephropathy].

Erley C.

Radiologe. 2007 Sep;47(9):761-7. Review. German.

PMID:
17823784
4.

Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.

Walker PD, Brokering KL, Theobald JC.

Pharmacotherapy. 2003 Dec;23(12):1617-26. Review.

PMID:
14695041
5.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
6.

[Contrast induced nephropathy].

Hörl WH.

Wien Klin Wochenschr. 2009;121(1-2):15-32. doi: 10.1007/s00508-009-1145-3. Review. German.

PMID:
19263010
7.

Contrast-induced nephropathy: a review.

Sanaei-Ardekani M, Movahed MR, Movafagh S, Ghahramani N.

Cardiovasc Revasc Med. 2005 Apr-Jun;6(2):82-8. Review.

PMID:
16263365
9.

Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.

Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F.

J Crit Care. 2013 Oct;28(5):701-9. doi: 10.1016/j.jcrc.2013.03.007. Epub 2013 May 15.

PMID:
23683568
10.
11.

Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials.

Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR.

Int Urol Nephrol. 2009;41(3):617-27. doi: 10.1007/s11255-009-9569-2. Epub 2009 Apr 25.

PMID:
19396567
12.

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.

Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK.

Catheter Cardiovasc Interv. 2002 Nov;57(3):279-83.

PMID:
12410497
13.

Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.

Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D.

Nephrol Dial Transplant. 2009 Oct;24(10):3103-7. doi: 10.1093/ndt/gfp306. Epub 2009 Jun 23.

PMID:
19549691
14.

Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.

Benko A, Fraser-Hill M, Magner P, Capusten B, Barrett B, Myers A, Owen RJ; Canadian Association of Radiologists.

Can Assoc Radiol J. 2007 Apr;58(2):79-87.

PMID:
17521052
15.

Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.

J Am Coll Cardiol. 2008 Aug 19;52(8):599-604. doi: 10.1016/j.jacc.2008.05.026.

16.

N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.

Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.

Am Heart J. 2009 Mar;157(3):576-83. doi: 10.1016/j.ahj.2008.11.010. Epub 2009 Feb 6.

PMID:
19249432
17.

N-acetylcysteine in the prevention of contrast-induced nephropathy.

Fishbane S.

Clin J Am Soc Nephrol. 2008 Jan;3(1):281-7. Epub 2007 Nov 14. Review.

18.

The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.

Iyisoy A, Celik T, Yuksel UC, Bugan B, Isik E.

Int J Cardiol. 2009 May 29;134(3):431-3; author reply 434. doi: 10.1016/j.ijcard.2007.12.123. Epub 2008 May 23.

PMID:
18501445
19.
20.

Preventive effect of N-acetylcysteine on contrast-induced nephropathy following coronary angiography and angioplasty.

Kamiyama N, Ogawa R, Hamada H, Ohno T, Asano R, Umemura J, Yoshida H.

Yakugaku Zasshi. 2008 Sep;128(9):1333-9.

Supplemental Content

Support Center